At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 11 enrolled
Drug / intervention
Deferiprone sustained-release +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pilot Study of the Pharmacokinetic Profile of a Single Dose of Deferiprone Sustained-Release Formulation in Healthy Volunteers
In Brief
A Phase 1 clinical trial evaluating Deferiprone sustained-release and Deferiprone immediate-release for Healthy. Completed, enrolled 11 participants across 1 site.
Detailed Summary
The purpose of this study was to evaluate the pharmacokinetic and safety profile of the sustained-release formulation of deferiprone under both fasting and fed conditions, and evaluate the relative bioavailability of this sustained-release formulation when compared to immediate-release formulation of deferiprone under fasting conditions.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesCanada
Collaborators--
Timeline
Phase 1CompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartMay 2014
Primary CompletionJun 2014
First PostedJul 2014
TodayJul 2026
First PostedJul 15, 2014
Enrollment StartMay 1, 2014
Primary CompletionJun 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 12.0 years ago
Interventions
Deferiprone sustained-releasedrug
Deferiprone sustained-release tablets
Deferiprone immediate-releasedrug
Deferiprone immediate-release tablets